ESC Premium Access

INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin

Congress Session

About the speaker

Doctor Patricia Oliveira Guimaraes

Duke Clinical Research Institute, Durham (United States of America)
0 follower

24 more presentations in this session

Impact of digoxin use on adverse outcomes in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study in China

Speaker: Miss S. Wu (Beijing, CN)


Rate-control treatment and clinical outcomes in patients with atrial fibrillation and obstructive lung disease

Speaker: Doctor S. You (Seoul, KR)


Efficacy of acute intravenous therapy with potassium, magnesium and metoprolol in recent-onset atrial fibrillation

Speaker: Miss A. Moser (Hamburg, DE)


Postoperative atrial fibrillation in patients with reduced ejection fraction heart failure undergoing cardiac surgery: ranolazine shortens time to conversion when added to amiodarone

Speaker: Professor J. Skoularigis (Larissa, GR)


Antiarrhythmic effect of the anti-influenza drug oseltamivir in an experimental whole-heart model of atrial fibrillation

Speaker: Doctor C. Ellermann (Muenster, DE)


Access the full session

Poster session 3 - Drug treatment

Speakers: Doctor P. Oliveira Guimaraes, Miss S. Wu, Doctor S. You, Miss A. Moser, Professor J. Skoularigis...

About the event



26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk